š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
The purpose of the SPIRIT IV Clinical Trial is to continue to evaluate the ...
Status
Completed
Location
Scottsdale Healthcare
Start Date
2006-08
Trial ID
NCT00307047
This study is divided into 5 arms: 1. Randomized Clinical Trial (RCT): Pro...
Status
Completed
Location
Baptist Medical Center Princeton
Start Date
2005-06
Trial ID
NCT00180479
XIENCE VĀ® India is a prospective, open-label, multi-center, observational, ...
Status
Completed
Location
CARE Hospital
Start Date
2008-06
Trial ID
NCT00631228
Treatments Being Tested
To evaluate the safety and efficacy of the Absorb BVS System compared to th...
Status
Completed
Location
Abbott Vascular
Start Date
2013-07
Trial ID
NCT01923740
Treatments Being Tested
The target enrollment goal for the trial was to enroll 36 subjects. However...
Status
Terminated
Location
Austin Health
Start Date
2011-11
Trial ID
NCT01308346
To evaluate the safety and effectiveness of the 2.25 mm XIENCE VĀ® Everolimu...
Status
Terminated
Location
Scottsdale Healthcare
Start Date
2008-10
Trial ID
NCT00783796
Treatments Being Tested
Prospective, multicenter, registry of at least 11,000 (and up to 15,000) co...
Status
Completed
Location
Minneapolis Heart Institute
Start Date
2008-01
Trial ID
NCT00638794
Treatments Being Tested
The primary objective of this trial is to compare the safety and efficacy o...
Status
Completed
Location
Cardiology, PC
Start Date
2017-10-13
Trial ID
NCT03168776
Treatments Being Tested
This study is a prospective, multi-center, open-label, randomized controlle...
Status
Unknown
Location
The General Hospital of Shenyang Military
Start Date
2017-11-10
Trial ID
NCT03040934
A prospective, active control, open-label, multinational, randomized clinic...
Status
Unknown
Location
Multiple Locations
Start Date
2019-09-15
Trial ID
NCT03721614